Theon International (THEON) H2 2025 earnings summary

Executive summary

• Achieved record order intake of EUR 1.3 billion, driven by landmark contracts and strong demand, with a book-to-bill ratio of 3x, significantly exceeding targets and market expectations.

• Revenue grew 26% year-over-year to EUR 443.4 million, following strong prior-year growth and nearly 50% CAGR since 2019.

• Adjusted EBIT rose 28% to EUR 116.1 million, with margin expansion to 26.2%, highlighting disciplined cost management and profitable growth.

• Strategic investments, acquisitions, and partnerships, including a EUR 150 million rights issue and extended agreements with Exosens and Rheinmetall, reinforced long-term positioning.

• Expanded global footprint and diversified revenue mix, with Europe now representing 75% of revenue, down from 82%, and growing contributions from Americas and Asia.

Financial highlights

• Adjusted EBITDA increased 29% to EUR 120 million, with margin up to 27.1% and high cash conversion at 84.5%.

• Net income reached EUR 81.2 million, up 20% year-over-year, marking another record profit.

• Operating cash flow improved from negative in 2024 to EUR 45.5 million in 2025, reflecting tighter working capital control.

• Capital expenditure rose to EUR 18.7 million, focused on new product design, capacity expansion, and new facilities in Denmark, South Korea, and Belgium.

• Secured a EUR 300 million revolving credit facility, supporting a strong and flexible balance sheet.

Outlook and guidance

• Revenue guidance for 2026 set at EUR 570–600 million, with leading margins and increased CapEx to EUR 30 million.

• Ambition to reach EUR 1 billion in revenue by 2029, one year ahead of previous target.

• Full-year dividend proposed at EUR 0.31 per share, at the upper end of the 20–30% payout range.

• Continued focus on diversification, M&A, and maintaining a book-to-bill ratio above 1x to support backlog visibility.

• Medium-term organic growth target above 15% per annum, supported by bolt-on M&A.